Bladder Cancer
The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer.
February 16, 2024
Population Estimates of Ovarian Cancer Risk in a Cohort of Patients with Bladder Cancer.
February 15, 2024
Intravesical thermochemotherapy in the treatment of high-risk and very high-risk non-muscle-invasive urothelial bladder cancer: a single-arm study.
February 15, 2024
Advances in diagnosis and treatment of bladder cancer.
February 14, 2024
Pathology focused review of morphologic subtypes and molecular variants of urothelial carcinoma with an emphasis on clinical/treatment relevance.
February 12, 2024
Successful bladder-sparing partial cystectomy for muscle-invasive domal urothelial carcinoma with sarcomatoid differentiation: a case report.
February 8, 2024
Association of Age with Non-muscle-invasive Bladder Cancer: Unearthing a Biological Basis for Epidemiological Disparities?
February 7, 2024
Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression in Non-muscle-invasive Bladder Cancer.
February 7, 2024
HPV and Squamous Cell Carcinoma of the Bladder - Expert Commentary
February 6, 2024